BioTechX Europe 2025 hosted 70 start-ups from across the biotech and genomics space, working on cutting-edge platform technologies and pioneering AI solutions. For 2026, we are debuting our new start-up and innovation track for investors and pre-series A companies.
This is a unique opportunity to exhibit, network, and pitch to a global audience of pharma, biotech, and investment professionals.
Questions?
Contact Suraiya Hall
Pre-Series A funding & fewer than 15 employees.
Your company must be 5 years old or younger.
3x attendance passes to the full 3-day congress.
1m² pod with graphics provided.
Pre-event marketing on our website and social media.
Investor matching and access to the Terrapinn App.
Secure a 10-minute on-stage pitching slot to present your value proposition deck to our portfolio of VCs, Accelerators, and Angel Investors. We aim to provide a varied portfolio of investors based on your specific funding needs.